(Q33298585)

25 July 2017

title

Oncolytic adenoviruses kill breast cancer initiating CD44+CD24-/low cells (English)

1 reference

25 July 2017

1 reference

1 reference

1 reference

11

Akseli Hemminki

1 reference

25 July 2017

7

Tanja Hakkarainen

1 reference

25 July 2017

8

Anna Kanerva

1 reference

25 July 2017

10

Sari Pesonen

1 reference

25 July 2017

Minna Eriksson

1

1 reference

25 July 2017

Kilian Guse

2

1 reference

25 July 2017

Gerd Bauerschmitz

3

1 reference

25 July 2017

Pekka Virkkunen

4

1 reference

25 July 2017

Maija Tarkkanen

5

1 reference

25 July 2017

Minna Tanner

6

1 reference

25 July 2017

Renee A Desmond

9

1 reference

25 July 2017

publication date

11 September 2007

1 reference

25 July 2017

1 reference

25 July 2017

volume

15

1 reference

25 July 2017

issue

12

1 reference

25 July 2017

page(s)

2088-2093

1 reference

Prospective identification of tumorigenic breast cancer cells

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Breast cancer stem cells: an overview.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Applying the principles of stem-cell biology to cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Characterization of a side population of cancer cells from human gastrointestinal system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Novel method for the isolation and characterisation of the putative prostatic stem cell

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

1 reference

7 January 2021

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Evaluation of E1-mutant adenoviruses as conditionally replicating agents for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Impact of E1a modifications on tumor-selective adenoviral replication and toxicity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Infectivity-enhanced adenoviruses deliver efficacy in clinical samples and orthotopic models of disseminated gastric cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Employment of liver tissue slice analysis to assay hepatotoxicity linked to replicative and nonreplicative adenoviral agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Chlorpromazine and apigenin reduce adenovirus replication and decrease replication associated toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

1 reference

7 January 2021

Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Systemic efficacy of oncolytic adenoviruses in imagable orthotopic models of hormone refractory metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

A heparan sulfate-targeted conditionally replicative adenovirus, Ad5.pk7-Delta24, for the treatment of advanced breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Tumour stem cells and drug resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

SoxB transcription factors specify neuroectodermal lineage choice in ES cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

P2Y-like receptor, GPR105 (P2Y14), identifies and mediates chemotaxis of bone-marrow hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

In vivo molecular chemotherapy and noninvasive imaging with an infectivity-enhanced adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Gene transfer approaches for gynecological diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Utility of TK/GCV in the context of highly effective oncolysis mediated by a serotype 3 receptor targeted oncolytic adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Treatment of prostate cancer with Ad5/3Delta24hCG allows non-invasive detection of the magnitude and persistence of virus replication in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Luciferase imaging for evaluation of oncolytic adenovirus replication in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Noninvasive imaging for evaluation of the systemic delivery of capsid-modified adenoviruses in an orthotopic model of advanced lung cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300300

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300300

1 reference

25 July 2017

1 reference